866-997-4948(US-Canada Toll Free)

Bladder Cancer Global Clinical Trials Review, H2, 2011

Published By :

GlobalData

Published Date : Sep 2011

Category :

Bladder Cancer

No. of Pages : 119 Pages


GlobalData's clinical trial report, Bladder Cancer Global Clinical Trials Review, H2, 2011" provides data on the Bladder Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bladder Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents


Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Bladder Cancer 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Bladder Cancer 25
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Endo Pharmaceuticals Inc. 37
Clinical Trial Overview of Endo Pharmaceuticals Inc. 37
Photocure ASA 38
Clinical Trial Overview of Photocure ASA 38
Celldex Therapeutics, Inc. 39
Clinical Trial Overview of Celldex Therapeutics, Inc. 39
Spectrum Pharmaceuticals, Inc. 40
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Merck & Co., Inc. 42
Clinical Trial Overview of Merck & Co., Inc. 42
Endo Pharmaceuticals Holdings Inc. 43
Clinical Trial Overview of Endo Pharmaceuticals Holdings Inc. 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Tengion, Inc. 45
Clinical Trial Overview of Tengion, Inc. 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Halozyme Therapeutics, Inc. 47
Clinical Trial Overview of Halozyme Therapeutics, Inc. 47
Predictive Biosciences, Inc. 48
Clinical Trial Overview of Predictive Biosciences, Inc. 48
Lahey Clinic Foundation, Inc. 49
Clinical Trial Overview of Lahey Clinic Foundation, Inc. 49
Oncogenex Pharmaceuticals, Inc. 50
Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc. 50
MacroGenics, Inc. 51
Clinical Trial Overview of MacroGenics, Inc. 51
Anthera Pharmaceuticals Inc. 52
Clinical Trial Overview of Anthera Pharmaceuticals Inc. 52
Hoosier Oncology Group, Inc. 53
Clinical Trial Overview of Hoosier Oncology Group, Inc. 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Memorial Sloan Kettering Cancer Center 54
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 54
European Organization for Research and Treatment of Cancer 56
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56
The University of Texas M. D. Anderson Cancer Center 59
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59
Southwest Oncology Group 61
Clinical Trial Overview of Southwest Oncology Group 61
Baylor College of Medicine 62
Clinical Trial Overview of Baylor College of Medicine 62
The University of Chicago 63
Clinical Trial Overview of The University of Chicago 63
Radiation Therapy Oncology Group 64
Clinical Trial Overview of Radiation Therapy Oncology Group 64
Stanford University 65
Clinical Trial Overview of Stanford University 65
University of Michigan 66
Clinical Trial Overview of University of Michigan 66
University of Michigan Comprehensive Cancer Center 67
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 67
USC Norris Comprehensive Cancer Center 68
Clinical Trial Overview of USC Norris Comprehensive Cancer Center 68
Roswell Park Cancer Institute 69
Clinical Trial Overview of Roswell Park Cancer Institute 69
Dana-Farber Cancer Institute 70
Clinical Trial Overview of Dana-Farber Cancer Institute 70
Wake Forest University 71
Clinical Trial Overview of Wake Forest University 71
Inselspital, University Hospital Bern 72
Clinical Trial Overview of Inselspital, University Hospital Bern 72
University Hospital Inselspital, Berne 73
Clinical Trial Overview of University Hospital Inselspital, Berne 73
University of Wisconsin Madison 74
Clinical Trial Overview of University of Wisconsin Madison 74
Fox Chase Cancer Center 75
Clinical Trial Overview of Fox Chase Cancer Center 75
University of Colorado 76
Clinical Trial Overview of University of Colorado 76
Institute of Cancer Research 77
Clinical Trial Overview of Institute of Cancer Research 77
Pierre Fabre Medicament 78
Clinical Trial Overview of Pierre Fabre Medicament 78
GE Healthcare 79
Clinical Trial Overview of GE Healthcare 79
Key Clinical Profiles 80
 

Appendix 115
Abbreviations 115
Definitions 115
Research Methodology 117
Secondary Research 117
About GlobalData 118
Contact Us 118
Disclaimer 118
Source 119

List of Table

 

Bladder Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2011*

Bladder Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*

Bladder Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, BRIC Countries, 2011*

Bladder Cancer Therapeutics Clinical Trials, G7 Countries, 2011*

Bladder Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*

Bladder Cancer Therapeutics Clinical Trials, E7 Countries, 2011*

Bladder Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*

Bladder Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2011*

Bladder Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*

Bladder Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*

Bladder Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2011*

Bladder Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*

Bladder Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2011*

Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010

Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011*

Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*

Bladder Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Photocure ASA, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Holdings Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tengion, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Halozyme Therapeutics, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Predictive Biosciences, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lahey Clinic Foundation, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoosier Oncology Group, Inc., 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris Comprehensive Cancer Center, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Inselspital, University Hospital Bern, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Cancer Research, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierre Fabre Medicament, 2011*

Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2011*

List of Chart


Bladder Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 9
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Bladder Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 15
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Bladder Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Bladder Cancer Therapeutics Clinical Trials, G7 Countries (%), 2011* 18
Bladder Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Bladder Cancer Therapeutics Clinical Trials, E7 Countries (%), 2011* 20
Bladder Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 22
Bladder Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 23
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 30
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 31
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 33
Bladder Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 35
GlobalData Methodology 117

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *